Logo image of CRON.CA

CRONOS GROUP INC (CRON.CA) Stock Analyst Ratings

TSX:CRON - Toronto Stock Exchange - CA22717L1013 - Common Stock - Currency: CAD

2.78  +0.05 (+1.83%)

Buy % Consensus

75

ChartMill assigns a Buy % Consensus number of 75% to CRON.CA. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 3.64. This target is 30.84% above the current price.
CRON.CA was analyzed by 11 analysts. The buy percentage consensus is at 75. So analysts seem to be have mildly positive about CRON.CA.
In the previous month the buy percentage consensus was at a similar level.
CRON.CA was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
CRON.CA Historical Analyst RatingsCRON.CA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -96 -87 -78 -69 -60 -51 -42 -33 -24 -15 -6 5 10 15 20

Price Target & Forecast

Price Low Median Mean High 2.782.793.063.645.25 - 0.27% 10.07% 30.84% 88.85%
CRON.CA Current Analyst RatingCRON.CA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4
Up and Down Grades
Date Firm Action Rating
2022-11-08 MKM Partners Downgrade
2022-10-07 Morningstar Inc. Downgrade Buy
2022-09-30 Barclays Downgrade
2022-08-15 STA Research Maintains Buy
2022-08-12 Jefferies Financial LLC Downgrade
2022-08-12 MKM Partners Downgrade
2022-07-30 Raymond James Capital Reiterate Buy
2022-07-29 Raymond James Capital Upgrade Outperform
2022-07-28 Canaccord Capital Upgrade Buy
2022-07-19 Cowen Downgrade
2022-05-13 Bank of America Securities Initiate Sell
2022-05-12 Jefferies Financial LLC Upgrade
2022-05-11 Canaccord Capital Upgrade Hold
2022-05-11 Morningstar Maintains Buy
2022-05-09 Raymond James Capital Upgrade Outperform
2022-03-22 STA Research Initiate Buy
2022-03-22 Barclays Maintains Underweight
2022-03-08 Jefferies Financial LLC Downgrade
2022-03-07 Piper Sandler Initiate Hold
2022-03-02 Raymond James Capital Initiate Outperform
2022-03-02 Morningstar Maintains Buy
2022-03-02 MKM Partners Initiate Buy
2022-02-22 Raymond James Capital Downgrade Outperform
2022-02-22 Canaccord Capital Initiate Sell
2022-02-22 Raymond James Financial Downgrade Outperform
2022-01-27 Jefferies Downgrade Hold
2021-11-23 Barclays Initiate Underweight
2021-08-24 Raymond James Financial Upgrade Ouperform
2021-08-11 Jefferies Upgrade
2021-08-10 MKM Partners Downgrade Buy